CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 340 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,370 shares (to pay taxes)
- 4 Grant or award Director acquired 1,523 shares (grant or award)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 1,134 shares (to pay taxes)
- 4 Grant or award Director acquired 1,523 shares (grant or award)
- 4 Shares withheld for taxes SVP, General Counsel gave up 1,325 shares (to pay taxes)
- 4 Grant or award Director acquired 1,523 shares (grant or award)
- 4 Grant or award Director acquired 1,523 shares (grant or award)
- 4 Grant or award Director acquired 1,523 shares (grant or award)
- 4 Grant or award Director acquired 1,523 shares (grant or award)
- 4 Shares withheld for taxes Chief Tech Ops Officer gave up 252 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, General Counsel gave up 196 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 378 shares (to pay taxes)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 522 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 4,211 shares (to pay taxes)
- 4 Open-market sale Director sold 858 shares at $109.92 ($94,311)
- 4 Open-market buy Director bought 57,100 shares at an average $104.43 ($5,963,124)
Page 8 of 34 · 672 filings